Buy Rainbow Childrens; target of Rs 1650: Choice Institutional Equities

What happened

Choice Institutional Equities maintained a target price of Rs 1,650 on Rainbow Childrens and changed its rating to BUY from ADD after a recent stock correction. The firm expects expansion from more than 2,500 beds to over 5,000 beds.

Confirmed

Global impact / market context

A BUY rating from ADD means the broker sees a better return after the share price fell. The Rs 1,650 target implies the analyst expects expanding bed capacity and technology spending to lift patient numbers and profit growth.

Analyst inference

The report projects revenue, EBITDA and profit after tax to grow at annual rates of 20.6%, 21.9% and 26.9% over FY26 to FY29E. It values the stock at 20 times EV/EBITDA, which means enterprise value divided by earnings before interest, tax, depreciation and amortisation, down from 22 times.

Analyst inference

What to watch

1. Watch whether Rainbow Childrens adds beds toward its plan of over 5,000 from more than 2,500, including a pipeline of about 1,050 beds across multiple locations. Confirmed
2. Watch whether the One Rainbow Model, technology investments and clinical hiring translate into higher patient volumes, better bed occupancy and improved operational efficiency as the broker anticipates. Proposed
3. Watch whether actual revenue and profit growth track the forecast annual rates of 20.6% and 26.9% through the projected years, since a shortfall would weaken the case for the Rs 1,650 target. Analyst inference

Evidence

• Original source link unavailable